Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

NCT00005634 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Prostate Cancer
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: vorinostat

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]